Admission Date:  [**2201-7-10**]              Discharge Date:   [**2201-7-18**]  Date of Birth:  [**2148-5-5**]             Sex:   M  Service: SURGERY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 695**] Chief Complaint: Right lobe liver mass  Major Surgical or Invasive Procedure: [**2201-7-10**] Exploratory laparotomy, common bile duct lymph node biopsy x2, intraoperative ultrasound, wedge liver biopsy   History of Present Illness: The patient is a 53-year-old male who was recently hospitalized at [**Hospital1 18**] from [**6-24**] through [**2201-7-3**], for evaluation of jaundice.
A triphasic CT scan demonstrated a 7 mm lung nodule in the right upper lobe and ground-glass nodules left lower lobe that will require interval follow-up but do not appear to represent metastatic disease at this time.
He underwent preoperative placement of bilateral transhepatic catheter for decompression of the bile duct and to facilitate surgical resection should that be necessary.
Past Medical History: PMH: HTN  PSH: CCY [**8-/2200**], Appy '[**85**], Knee surgery, [**2201-6-24**]: ERCP, sphincterotomy, biliary stent placement, [**2201-6-26**]: PTC with left PTBD placement, [**2201-6-30**]: PTC with right anterior PTBD placement   Social History: Works for [**Location (un) 10059**] Springs, married with 2 daughters, minimal ETOH use, prior smoker, denies history of drug use or STD's   Family History: Non-significant for malignancy or liver disease  Physical Exam: Exam on discharge:  VS: 98.1 79 145/70 18 97RA Gen: AAOx3, pleasant and conversant in no distress CVS: Regular, no murmur Pulm: Clear bilaterally.
PTBD external drains x2 intact, capped, without drainage or induration.
Ext: Warm, without edema  Pertinent Results: [**2201-7-10**] Surgical Pathology: Procedure date     Tissue received     Report Date    Diagnosed by [**2201-7-10**] [**2201-7-10**] [**2201-7-14**] DR. [**Last Name (STitle) **] [**Last Name (NamePattern4) **]/vf .
External and internal biliary drains are partially seen in the upper abdomen.
[**2201-7-10**] 10:37AM   PT-12.3 INR(PT)-1.1 [**2201-7-10**] 10:37AM   PLT COUNT-379 [**2201-7-10**] 10:37AM   WBC-9.4 RBC-4.13* HGB-12.7* HCT-39.6* MCV-96 MCH-30.6 MCHC-31.9 RDW-13.2 [**2201-7-10**] 10:37AM   ALBUMIN-3.3* CALCIUM-8.5 PHOSPHATE-5.6*# MAGNESIUM-2.1 [**2201-7-10**] 10:37AM   ALT(SGPT)-114* AST(SGOT)-109* ALK PHOS-330* TOT BILI-3.0* [**2201-7-10**] 10:37AM   GLUCOSE-120* UREA N-13 CREAT-0.9 SODIUM-140 POTASSIUM-4.6 CHLORIDE-106 TOTAL CO2-24 ANION GAP-15  Brief Hospital Course: Mr. [**Known lastname 1557**] presented on [**2201-7-10**] for planned surgical intervention for his locally advanced cholangiocarcinoma.
After appropriate preparation and informed consent was obtained, he underwent exploratory laparotomy, CBD lymph node biopsies, intraoperative ultrasound, and wedge liver biopsy, which he tolerated well.
On POD2, clear liquids were started, which he tolerated well, his IV fluids were heplocked and he was transitioned to oral pain medication.
His foley catheter was removed at midnight and he voided without difficulty.
His home medications were resumed and he continued to ambulate independently.
On [**7-14**], Mr. [**Known lastname 1557**] continued to tolerated a regular diet, ambulate, and report good pain control with oral medication.
A heparin drip was initiated, and Mr. [**Known lastname 1557**] was initially stable on 2L NC.
Echocardiography revealed mild RV dilation without valvular dysfunction, and his heparin drip was continued.
An arterial line was placed to facilitate timely PTT monitoring and hemodynamic.
On [**7-17**], Mr. [**Known lastname 1557**] was transitioned to lovenox and the heparin drip weaned to off.
Lovenox prescription was called in to his home pharmacy.
On [**7-18**], Mr. [**Known lastname 1557**] was tolerating a regular diet, ambulating independently (cleared by PT), reporting good pain control on oral medication, and maintaining good oxygen saturation on room air without shortness of breath.
He and his family received lovenox teaching and demonstrated their ability to provide his treatment at home.
VNA service was arranged for drain care.
Prescriptions for pain medication and a bowel regimen were provided.
Mr. [**Known lastname 1557**] will continue his Cipro for cholangitis prophylaxis.
Medications on Admission: [**Last Name (un) 1724**]: Keflex 500'''', cipro 500', dilaudid [**3-14**] q4h PRN, losartan 50', urosdiol 300'', colace 100'', MoM PRN, [**Name2 (NI) **] 8.6''   Discharge Medications: 1.
Ciprofloxacin HCl 500 mg PO Q24H RX *ciprofloxacin 500 mg daily Disp #*30 Tablet Refills:*1 2.
Docusate Sodium 100 mg PO BID 3.
Losartan Potassium 50 mg PO DAILY 4.
HYDROmorphone (Dilaudid) 2-4 mg PO Q4H:PRN pain RX *Dilaudid 2 mg every four (4) hours Disp #*40 Tablet Refills:*0 5.
Ursodiol 300 mg PO BID 7.
Enoxaparin Sodium 120 mg SC Q12H RX *enoxaparin 120 mg/0.8 mL twice a day Disp #*60 Syringe Refills:*3   Discharge Disposition: Home With Service  Facility: [**Hospital1 **] VNA, [**Hospital1 1559**]  Discharge Diagnosis: Intrahepatic cholangiocarcinoma with lymph node metastases.
-Continue to change dry gauze dressing over drain sites daily.
-you may shower -No driving if taking pain medication - Please monitor for signs of increased bleeding to include nose bleeds, rectal bleeding, easy bruising.
You have been started on lovenox for management of the newly diagnosed pulmonary emboli.
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 707**], MD, PHD[**MD Number(3) 708**]:[**Telephone/Fax (1) 673**] Date/Time:[**2201-7-22**] 2:40 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 6050**], MD Phone:[**Telephone/Fax (1) 8770**] Date/Time:[**2201-7-27**] 3:00                                [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 707**] MD, [**MD Number(3) 709**]
